Lilly, BI cleared to market Basaglar long-acting insulin
INDIANAPOLIS and RIDGEFIELD, Conn. — Eli Lilly and Co. and Boehringer Ingelheim Pharmaceuticals Inc. have received approval for Basaglar long-acting…
December 18, 2015 by Chain Drug Review Pharmacy, Supplier News
INDIANAPOLIS and RIDGEFIELD, Conn. — Eli Lilly and Co. and Boehringer Ingelheim Pharmaceuticals Inc. have received approval for Basaglar long-acting…
December 18, 2015 by Chain Drug Review Pharmacy, Supplier News
KENILWORTH, N.J. — Merck has received approval from the Food and Drug Administration for an expanded age indication for Gardasil…
December 17, 2015 by Chain Drug Review Pharmacy, Supplier News
LONDON and OSAKA, Japan — AstraZeneca plans to acquire the core respiratory business of Takeda Pharmaceutical Co. Ltd. for $575…
December 16, 2015 by Chain Drug Review Pharmacy, Supplier News
ROCKVILLE, Md. — Peter Greenleaf, chief executive officer of Sucampo Pharmaceuticals Inc., has been appointed as chairman of the board.…
December 16, 2015 by Chain Drug Review Supplier News
MINNEAPOLIS — General Mills reports that it’s making headway in its effort sodium by 20% across 10 key U.S. retail…
December 15, 2015 by Chain Drug Review Leading Headlines, Pharmacy, Supplier News
NEW YORK — Sanofi and Boehringer Ingelheim are in talks to swap their animal health and consumer health care businesses, respectively. The companies…
December 15, 2015 by Chain Drug Review Supplier News
HERSHEY, Pa. — The Hershey Co. has hired sales veteran Rob Gehring as global chief sales officer. Hershey said Gehring is slated to…
December 15, 2015 by Chain Drug Review Pharmacy, Supplier News
DUBLIN, Ireland — Allergan plc has released Viberzi (eluxadoline), a treatment for irritable bowel syndrome with diarrhea (IBS-D), to U.S. pharmacies. The company…